Published in Br J Clin Pharmacol on January 01, 2010
Effect of statin treatment on short term mortality after pneumonia episode: cohort study. BMJ (2011) 2.32
Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis. J Lipid Res (2011) 1.69
Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study. PLoS Med (2010) 1.66
Statin use in giant cell arteritis: a retrospective study. J Rheumatol (2013) 0.98
Design of cohort studies in chronic diseases using routinely collected databases when a prescription is used as surrogate outcome. BMC Med Res Methodol (2011) 0.83
Association of the use of statins with disease activity and functional status in Puerto Ricans with rheumatoid arthritis. P R Health Sci J (2014) 0.77
Editors' pick 2009. Br J Clin Pharmacol (2010) 0.75
Effect of Atorvastatin on the Disease Activity and Severity of Rheumatoid Arthritis: Double-Blind Randomized Controlled Trial. J Clin Diagn Res (2016) 0.75
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet (1994) 40.72
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med (1995) 28.35
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med (2001) 7.51
Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet (2004) 6.24
Statins as a newly recognized type of immunomodulator. Nat Med (2000) 5.00
Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet (2006) 4.42
Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet (2004) 3.95
Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov (2005) 3.92
Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1999) 3.90
Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database. Int J Epidemiol (2006) 3.36
The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf (2005) 3.24
Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med (1995) 3.11
Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors. Nat Rev Drug Discov (2003) 2.69
A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol (2003) 2.37
Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Circulation (1997) 1.70
Inhibition of proinflammatory cytokine production by pravastatin. Lancet (1999) 1.67
Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis. Eur J Pharmacol (2005) 1.22
Statins in rheumatoid arthritis--two birds with one stone? Lancet (2004) 1.17
Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis. Ann Rheum Dis (2008) 1.08
Effects of pravastatin in murine collagen-induced arthritis. Rheumatol Int (2006) 0.90
Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients. J Heart Lung Transplant (2005) 0.89
Statins and the risk of colorectal cancer. N Engl J Med (2005) 0.87
Treatment with statins does not exhibit a clinically relevant corticosteroid-sparing effect in patients with giant cell arteritis. Arthritis Rheum (2004) 0.85
Impact of simvastatin and losartan on antiinflammatory effect: in vitro study. J Cardiovasc Pharmacol (2007) 0.80
Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA (2006) 11.87
Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med (2004) 11.47
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA (2012) 4.73
Effects of training on quality of peer review: randomised controlled trial. BMJ (2004) 4.20
Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ (2011) 4.12
Multiple imputation: current perspectives. Stat Methods Med Res (2007) 3.63
Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs. BMJ (2012) 2.88
Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials. Stroke (2007) 2.86
Comments on 'Fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death'. Stat Med (2008) 2.37
Propensity scores: from naive enthusiasm to intuitive understanding. Stat Methods Med Res (2011) 2.25
Eliciting and using expert opinions about dropout bias in randomized controlled trials. Clin Trials (2007) 2.15
Strategies for multiple imputation in longitudinal studies. Am J Epidemiol (2010) 2.15
Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network. J Clin Psychiatry (2011) 1.84
Injury patterns in big ten conference football. Am J Sports Med (2004) 1.76
A rapid assessment process for clinical informatics interventions. AMIA Annu Symp Proc (2008) 1.74
Including all individuals is not enough: lessons for intention-to-treat analysis. Clin Trials (2012) 1.71
Effect on peer review of telling reviewers that their signed reviews might be posted on the web: randomised controlled trial. BMJ (2010) 1.66
Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells. Stat Med (2009) 1.64
A model for the future conduct of pharmacovigilance. Pharmacoepidemiol Drug Saf (2003) 1.57
Arcsine test for publication bias in meta-analyses with binary outcomes. Stat Med (2008) 1.49
Identifying adverse events of vaccines using a Bayesian method of medically guided information sharing. Drug Saf (2012) 1.46
Development of paediatric quality of inpatient care indicators for low-income countries - A Delphi study. BMC Pediatr (2010) 1.44
The relationship between quality of research and citation frequency. BMC Med Res Methodol (2006) 1.40
The Prevalence of Huntington's Disease. Neuroepidemiology (2016) 1.40
Comparison of imputation and modelling methods in the analysis of a physical activity trial with missing outcomes. Int J Epidemiol (2004) 1.29
Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions. Pediatr Infect Dis J (2007) 1.23
Consumer involvement in consent document development: a multicenter cluster randomized trial to assess study participants' understanding. Clin Trials (2006) 1.17
Recommended practices for computerized clinical decision support and knowledge management in community settings: a qualitative study. BMC Med Inform Decis Mak (2012) 1.17
Developing appropriate methods for cost-effectiveness analysis of cluster randomized trials. Med Decis Making (2011) 1.10
STRengthening analytical thinking for observational studies: the STRATOS initiative. Stat Med (2014) 1.01
Persistent paper: the myth of "going paperless". AMIA Annu Symp Proc (2009) 1.01
Evaluation of two-fold fully conditional specification multiple imputation for longitudinal electronic health record data. Stat Med (2014) 1.00
Last observation carry-forward and last observation analysis. Stat Med (2004) 1.00
Comparison of random forest and parametric imputation models for imputing missing data using MICE: a CALIBER study. Am J Epidemiol (2014) 0.98
Drug safety and regulation. BMJ (2005) 0.94
Methods for covariate adjustment in cost-effectiveness analysis that use cluster randomised trials. Health Econ (2012) 0.94
A brief measure of perceived understanding of informed consent in a clinical trial was validated. J Clin Epidemiol (2006) 0.93
The use of regression models for medians when observed outcomes may be modified by interventions. Stat Med (2003) 0.92
Multiple perspectives on the meaning of clinical decision support. AMIA Annu Symp Proc (2010) 0.92
Practical considerations for sensitivity analysis after multiple imputation applied to epidemiological studies with incomplete data. BMC Med Res Methodol (2012) 0.90
Statistically significant papers in psychiatry were cited more often than others. J Clin Epidemiol (2007) 0.90
Effect of a multi-faceted quality improvement intervention on inappropriate antibiotic use in children with non-bloody diarrhoea admitted to district hospitals in Kenya. BMC Pediatr (2011) 0.88
Multiple perspectives on the meaning of clinical decision support. AMIA Annu Symp Proc (2010) 0.87
A signal detection method to detect adverse drug reactions using a parametric time-to-event model in simulated cohort data. Drug Saf (2012) 0.86
Missing data: discussion points from the PSI missing data expert group. Pharm Stat (2010) 0.86
The influence of formulation and medicine delivery system on medication administration errors in care homes for older people. BMJ Qual Saf (2011) 0.86
The performance of multiple imputation for missing covariates relative to complete case analysis. Stat Med (2010) 0.85
Laboratory monitoring and adverse patient outcomes with antihypertensive therapy in primary care. Pharmacoepidemiol Drug Saf (2010) 0.85
Empirical evaluation suggests Copas selection model preferable to trim-and-fill method for selection bias in meta-analysis. J Clin Epidemiol (2010) 0.85
Oversight: a retrospective study of biochemical monitoring in patients beginning antihypertensive drug treatment in primary care. Br J Clin Pharmacol (2010) 0.84
Non-specific effects of BCG? J Infect Dis (2011) 0.84
Adjusting treatment comparisons to account for non-randomized interventions: an example from an angina trial. Stat Med (2003) 0.83
Design of cohort studies in chronic diseases using routinely collected databases when a prescription is used as surrogate outcome. BMC Med Res Methodol (2011) 0.83
Comments on 'Empirical vs natural weighting in random effects meta-analysis' by JJ Shuster, Statistics in Medicine 2009; 26, Published online, DOI: 10.1002/sim.3607. Stat Med (2010) 0.82
Relationship between polycystic ovaries, body mass index and insulin resistance. Acta Obstet Gynecol Scand (2003) 0.81
Are large trials less reliable than small trials? J Clin Epidemiol (2009) 0.81
Verteporfin photodynamic therapy cohort study: report 2: clinical measures of vision and health-related quality of life. Ophthalmology (2009) 0.81
Verteporfin photodynamic therapy cohort study: report 1: effectiveness and factors influencing outcomes. Ophthalmology (2009) 0.80
Drug safety and the media. Br J Clin Pharmacol (2006) 0.80
Relaxing the independent censoring assumption in the Cox proportional hazards model using multiple imputation. Stat Med (2014) 0.79
Optimal CD4 count for initiating HIV treatment: impact of CD4 observation frequency and grace periods, and performance of dynamic marginal structural models. Epidemiology (2014) 0.77
Variceal bleeding in primary biliary cirrhosis patients: a subgroup with improved prognosis and a model to predict survival after first bleeding. Eur J Gastroenterol Hepatol (2009) 0.77
Identifying influential observations in Bayesian models by using Markov chain Monte Carlo. Stat Med (2011) 0.76
Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink. Br J Clin Pharmacol (2015) 0.75
Complete-cases analysis is appropriate for randomised trials with pre-test-post-test designs. Psychiatry Res (2009) 0.75
QRISK validation and evaluation. Bespoke cohort studies needed. BMJ (2009) 0.75
Verteporfin photodynamic therapy cohort study: report 3: cost effectiveness and lessons for future evaluations. Ophthalmology (2009) 0.75
Suicide-related events in young people following prescription of SSRIs and other antidepressants: a self-controlled case series analysis. BMJ Open (2013) 0.75
Developing tools for the safety specification in risk management plans: lessons learned from a pilot project. Pharmacoepidemiol Drug Saf (2008) 0.75
Special issue marking 40 years of the MSc Medical Statistics at the London School of Hygiene & Tropical Medicine. Stat Methods Med Res (2012) 0.75
An explanation for the effectiveness of the 'Draijer' algorithm for high speed laser Doppler perfusion imaging. Med Biol Eng Comput (2012) 0.75